Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson's disease

被引：0
|
作者：
Vinata Vedam-Mai [1 ]
Jacob M.Samuel [2 ]
Boone M.Prentice [2 ]
机构：
[1] Department of Neurology, University of Florida
[2] Department of Chemistry, University of Florida
来源：
Neural Regeneration Research | 2024年 / 06期
关键词：
D O I：
暂无
中图分类号：
R742.5 [震颤麻痹综合征];
学科分类号：
1002 ;
摘要：
Parkinson’s disease–A lipidopathy? The histopathological hallmark of Parkinson’s disease(PD) and dementia with Lewy bodies are inclusions enriched in α-synuclein(α-syn), known as Lewy bodies, which are not only composed of proteins, but also a core of lipid species. PD has been thus far principally thought of as a “proteinopathy” caused by the misfolding of α-syn. However,
引用
收藏
页码：1179 / 1180
页数：2
相关论文
共 50 条
  • [41] Molecular Mapping of Neutral Lipids Using Silicon Nanopost Arrays and TIMS Imaging Mass Spectrometry
    Fincher, Jarod A.
    Djambazova, Katerina, V
    Klein, Dustin R.
    Dufresne, Martin
    Migas, Lukasz G.
    Van de Plas, Raf
    Caprioli, Richard M.
    Spraggins, Jeffrey M.
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2021, 32 (10) : 2519 - 2527
  • [42] Probing Alzheimer's disease using imaging mass spectrometry
    Smith, Kristie
    Kelley, Andrea
    Castellani, Rudolph J.
    Perry, George
    Bach, Stephan B. H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [43] Atomic and Molecular Mass Spectrometry Imaging
    Luptakova, Dominika
    Havlicek, Vladimir
    CHEMICKE LISTY, 2020, 114 (03): : 216 - 219
  • [44] Parkinson's disease molecular imaging: Up-to-date
    Baulieu, J. -L.
    Le-Pogam, A.
    Leborgne, A.
    Guilloteau, D.
    Prunier-Aesch, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (04): : 236 - 241
  • [45] Translational molecular imaging and drug development in Parkinson's disease
    Haider, Ahmed
    Elghazawy, Nehal H.
    Dawood, Alyaa
    Gebhard, Catherine
    Wichmann, Thomas
    Sippl, Wolfgang
    Hoener, Marius
    Arenas, Ernest
    Liang, Steven H.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [46] Molecular imaging of impulse control disorders in Parkinson’s disease
    Joonas Majuri
    Juho Joutsa
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2220 - 2222
  • [47] Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease
    de Natale, Edoardo R.
    Niccolini, Flavia
    Wilson, Heather
    Politis, Marios
    IMAGING IN MOVEMENT DISORDERS: IMAGING METHODOLOGY AND APPLICATIONS IN PARKINSON'S DISEASE, 2018, 141 : 131 - 172
  • [48] Challenges in molecular imaging of Parkinson's disease: A brief overview
    Kassiou, Michael
    Banati, Richard
    Holsinger, R. M. Damian
    Meikle, Steve
    BRAIN RESEARCH BULLETIN, 2009, 78 (2-3) : 105 - 108
  • [49] The molecular basis of dopaminergic brain imaging in Parkinson's disease
    Seibyl, J.
    Russell, D.
    Jennings, D.
    Marek, K.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (01): : 4 - 16
  • [50] Molecular imaging of impulse control disorders in Parkinson's disease
    Majuri, Joonas
    Joutsa, Juho
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) : 2220 - 2222
12345